Alopecia Treatment Market by Drug Type (Minoxidil, Finasteride, and Other Drug Types), Indication (Androgenic Alopecia, Alopecia Areata, Alopecia Totalis, and Others), and Distribution Channel (Hospitals Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2019–2026
|
A05945
|
Pages: 243
|
Jan
2020 |
352 Views
|
|
|
|
Author(s) :
Sayali Shinde
, Onkar Sumant
|
Tables: 88
|
Charts: 18
|
Formats*:
|
|
The global alopecia treatment market was valued at $2,736 million in 2018, and is projected to reach $3,935 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Alopecia is also called baldness or hair loss, a disorder that relates to hair loss from the scalp or any part of the body. It can happen in both male & female and at any age. There are different types of alopecia, which include androgenic alopecia, alopecia areata, alopecia totalis, and others. Alopecia is an autoimmune disorder where the immune system of the body attacks healthy hair follicles, leading to hair loss. Various drugs and surgical treatments such as hair transplantation, scalp reduction treatment, and others can be used for the treatment of alopecia condition. It is estimated that alopecia treatment market will show significant market growth over the forecast period, owing to rise in incidence and prevalence of chronic diseases such as arthritis, Polycystic Ovary syndrome (PCOS), cancer, and others; change in lifestyle along with rise in stress level; rise in geriatric population, hormonal imbalance, unhealthy diets; and increase in demand for alopecia treatment drugs. In addition, significant market potential in the developing regions is expected to offer lucrative opportunities for the market expansion during the forecast period.
Get more information on this report : Request Sample Pages
Alopecia Treatment Market Segmentation
The alopecia treatment market is segmented into drug type, indication, distribution channel, and region. By drug type, the market is categorized into minoxidil, finasteride, and other drug types. The indication covered in the study include androgenic alopecia, alopecia areata, alopecia totalis, and others. Depending on distribution channel, the market is classified into hospitals pharmacies, drug stores & retail pharmacies, and online pharmacies. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Segment Review
Based on drug type, the Alopecia Treatment Market is divided into minoxidil, finasteride, and other drug types. Presently, minoxidil dominates the global market, and is anticipated to continue this trend during the forecast period. The key factors that drive the market growth include increase in prevalence of chronic diseases such as depression, hypertension, arthritis, and cancer treatment that tend to hair loss from patient body; rise in demand for minoxidil drug for alopecia treatment; and increase in air & water pollution that harms the health of the hair and causes baldness & early breakage.
Alopecia Treatment Market
By Drug Type
Minoxidil is projected as one of the most lucrative segment.
Get more information on this report : Request Sample Pages
Based on indication, the global alopecia treatment market is divided into androgenic alopecia, alopecia areata, alopecia totalis, and others. The androgenic alopecia segment accounted for the majority of market share, owing to surge in incidence of androgenic alopecia condition, hormonal imbalance, unhealthy lifestyle, and rise in patient awareness regarding alopecia treatments.
Alopecia Treatment Market
By Indication
Androgenic Alopecia holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.
Get more information on this report : Request Sample Pages
Snapshot of the Asia-Pacific Alopecia Treatment Market
Asia-Pacific presents lucrative opportunities for the key players operating in the alopecia treatment market, owing to growth in awareness regarding alopecia treatment and rise in adoption of alopecia treatment products. Moreover, improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced medical facilities, development in R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare further contribute to the market growth. Some other factors such as surge in focus of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific countries to capture high growth opportunities in the market, high population base, and high disposable incomes are expected to drive the growth of alopecia treatment market in Asia-Pacific.
Alopecia Treatment Market
By Geography
Asia-Pacific region would exhibit the highest CAGR of 5.9% during 2019-2026.
Get more information on this report : Request Sample Pages
The key players profiled in this report include Capillus, LLC, Cipla Inc., Daiichi Sankyo Company, Limited, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Transitions Hair, Vitabiotics Ltd., and Vita-Cos-Med Klett-Loch GmbH.
Key Benefits for Stakeholders:
- The study provides an in-depth analysis of the alopecia treatment market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers Alopecia Treatment Market analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global alopecia treatment market growth.
Key Market Segments:
By Drug Type
- Minoxidil
- Finasteride
- Other Drug Types
By Indication
- Androgenic Alopecia
- Alopecia Areata
- Alopecia Totalis
- Others
By End User
- Hospitals Pharmacies
- Drug Stores & Retail Pharmacies
- Online Pharmacies
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in chronic diseases to lead to hair loss
3.4.1.2. Surge in global geriatric population
3.4.1.3. Increase in government expenditure on healthcare
3.4.2. Restraint
3.4.2.1. Poor demand in under developed countries
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.4.4. Impact analysis
CHAPTER 4: ALOPECIA TREATMENT MARKET, BY DRUG TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Minoxidil
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Finasteride
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Other drug types
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: ALOPECIA TREATMENT MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Androgenic alopecia
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Alopecia areata
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Alopecia totalis
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
CHAPTER 6: ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals pharmacies
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Drug stores & retail pharmacies
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Online pharmacies
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
CHAPTER 7: ALOPECIA TREATMENT MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. alopecia treatment market, by drug type
7.2.2.1.2. U.S. alopecia treatment market, by Indication
7.2.2.1.3. U.S. alopecia treatment market, by distribution channel
7.3. North America
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. U.S.
7.3.2.1.1. U.S. alopecia treatment market, by drug type
7.3.2.1.2. U.S. alopecia treatment market, by Indication
7.3.2.1.3. U.S. alopecia treatment market, by distribution channel
7.3.2.2. Canada
7.3.2.2.1. Canada alopecia treatment market, by drug type
7.3.2.2.2. Canada alopecia treatment market, by Indication
7.3.2.2.3. Canada alopecia treatment market, by distribution channel
7.3.2.3. Mexico
7.3.2.3.1. Mexico alopecia treatment market, by drug type
7.3.2.3.2. Mexico alopecia treatment market, by Indication
7.3.2.3.3. Mexico alopecia treatment market, by distribution channel
7.3.3. North America market size and forecast, by drug type
7.3.4. North America market size and forecast, by Indication
7.3.5. North America market size and forecast, by distribution channel
7.4. Europe
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Germany
7.4.2.1.1. Germany alopecia treatment market, by drug type
7.4.2.1.2. Germany alopecia treatment market, by Indication
7.4.2.1.3. Germany alopecia treatment market, by distribution channel
7.4.2.2. France
7.4.2.2.1. France alopecia treatment market, by drug type
7.4.2.2.2. France alopecia treatment market, by indication
7.4.2.2.3. France alopecia treatment market, by distribution channel
7.4.2.3. UK
7.4.2.3.1. UK alopecia treatment market, by drug type
7.4.2.3.2. UK alopecia treatment market, by indication
7.4.2.3.3. UK alopecia treatment market, by distribution channel
7.4.2.4. Italy
7.4.2.4.1. Italy alopecia treatment market, by drug type
7.4.2.4.2. Italy alopecia treatment market, by indication
7.4.2.4.3. Italy alopecia treatment market, by distribution channel
7.4.2.5. Spain
7.4.2.5.1. Spain alopecia treatment market, by drug type
7.4.2.5.2. Spain alopecia treatment market, by indication
7.4.2.5.3. Spain alopecia treatment market, by distribution channel
7.4.2.6. Rest of Europe
7.4.2.6.1. Rest of Europe alopecia treatment market, by drug type
7.4.2.6.2. Rest of Europe alopecia treatment market, by indication
7.4.2.6.3. Rest of Europe alopecia treatment market, by distribution channel
7.4.3. Europe market size and forecast, by drug type
7.4.4. Europe market size and forecast, by indication
7.4.5. Europe market size and forecast, by distribution channel
7.5. Asia-Pacific
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Japan
7.5.2.1.1. Japan alopecia treatment market, by drug type
7.5.2.1.2. Japan alopecia treatment market, by indication
7.5.2.1.3. Japan alopecia treatment market, by distribution channel
7.5.2.2. China
7.5.2.2.1. China alopecia treatment market, by drug type
7.5.2.2.2. China alopecia treatment market, by indication
7.5.2.2.3. China alopecia treatment market, by distribution channel
7.5.2.3. Australia
7.5.2.3.1. Australia alopecia treatment market, by drug type
7.5.2.3.2. Australia alopecia treatment market, by indication
7.5.2.3.3. Australia alopecia treatment market, by distribution channel
7.5.2.4. India
7.5.2.4.1. India alopecia treatment market, by drug type
7.5.2.4.2. India alopecia treatment market, by indication
7.5.2.4.3. India alopecia treatment market, by distribution channel
7.5.2.5. South Korea
7.5.2.5.1. South Korea alopecia treatment market, by drug type
7.5.2.5.2. South Korea alopecia treatment market, by indication
7.5.2.5.3. South Korea alopecia treatment market, by distribution channel
7.5.2.6. Rest of Asia-Pacific
7.5.2.6.1. Rest of Asia-Pacific alopecia treatment market, by drug type
7.5.2.6.2. Rest of Asia-Pacific alopecia treatment market, by indication
7.5.2.6.3. Rest of Asia-Pacific alopecia treatment market, by distribution channel
7.5.3. Asia-Pacific market size and forecast, by drug type
7.5.4. Asia-Pacific market size and forecast, by indication
7.5.5. Asia-Pacific market size and forecast, by distribution channel
7.6. LAMEA
7.6.1. Key market trends, growth factors, and opportunities
7.6.2. Market size and forecast, by country
7.6.2.1. Brazil
7.6.2.1.1. Brazil alopecia treatment market, by drug type
7.6.2.1.2. Brazil alopecia treatment market, by indication
7.6.2.1.3. Brazil alopecia treatment market, by distribution channel
7.6.2.2. Saudi Arabia
7.6.2.2.1. Saudi Arabia alopecia treatment market, by drug type
7.6.2.2.2. Saudi Arabia alopecia treatment market, by indication
7.6.2.2.3. Saudi Arabia alopecia treatment market, by distribution channel
7.6.2.3. South Africa
7.6.2.3.1. South Africa alopecia treatment market, by drug type
7.6.2.3.2. South Africa alopecia treatment market, by indication
7.6.2.3.3. South Africa alopecia treatment market, by distribution channel
7.6.2.4. Rest of LAMEA
7.6.2.4.1. Rest of LAMEA alopecia treatment market, by drug type
7.6.2.4.2. Rest of LAMEA alopecia treatment market, by indication
7.6.2.4.3. Rest of LAMEA alopecia treatment market, by distribution channel
7.6.3. LAMEA market size and forecast, by drug type
7.6.4. LAMEA market size and forecast, by indication
7.6.5. LAMEA market size and forecast, by distribution channel
LIST OF TABLES
TABLE 01. GLOBAL ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026 ($MILLION)
TABLE 02. MINOXIDIL ALOPECIA TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03. FINASTERIDE ALOPECIA TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. OTHER DRUG TYPES ALOPECIA TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 05. GLOBAL ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026 ($MILLION)
TABLE 06. ANDROGENIC ALOPECIA TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 07. ALOPECIA AREATA ALOPECIA TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 08. ALOPECIA TOTALIS ALOPECIA TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09. OTHERS ALOPECIA TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 10. GLOBAL ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 11. HOSPITALS PHARMACIES ALOPECIA TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 12. DRUG STORES & RETAIL PHARMACIES ALOPECIA TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 13. ONLINE PHARMACIES ALOPECIA TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 14. ALOPECIA TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 15. NORTH AMERICA ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 16. U.S. ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 17. U.S. ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 18. U.S. ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 19. NORTH AMERICA ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 20. U.S. ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 21. U.S. ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 22. U.S. ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 23. CANADA ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 24. CANADA ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 25. CANADA ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 26. MEXICO ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 27. MEXICO ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 28. MEXICO ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 29. NORTH AMERICA ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 30. NORTH AMERICA ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 31. NORTH AMERICA ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 32. EUROPE ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 33. GERMANY ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 34. GERMANY ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 35. GERMANY ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 36. FRANCE ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 37. FRANCE ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 38. FRANCE ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 39. UK ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 40. UK ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 41. UK ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 42. ITALY ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 43. ITALY ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 44. ITALY ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 45. SPAIN ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 46. SPAIN ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 47. SPAIN ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 48. REST OF EUROPE ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 49. REST OF EUROPE ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 50. REST OF EUROPE ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 51. EUROPE ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 52. EUROPE ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 53. EUROPE ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 54. ASIA-PACIFIC ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 55. JAPAN ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 56. JAPAN ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 57. JAPAN ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 58. CHINA ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 59. CHINA ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 60. CHINA ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 61. AUSTRALIA ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 62. AUSTRALIA ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 63. AUSTRALIA ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 64. INDIA ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 65. INDIA ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 66. INDIA ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 67. SOUTH KOREA ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 68. SOUTH KOREA ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 69. SOUTH KOREA ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 70. REST OF ASIA-PACIFIC ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 71. REST OF ASIA-PACIFIC ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 72. REST OF ASIA-PACIFIC ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 73. ASIA-PACIFIC ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 74. ASIA-PACIFIC ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 75. ASIA-PACIFIC ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 76. LAMEA ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 77. BRAZIL ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 78. BRAZIL ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 79. BRAZIL ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 80. SAUDI ARABIA ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 81. SAUDI ARABIA ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 82. SAUDI ARABIA ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 83. SOUTH AFRICA ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 84. SOUTH AFRICA ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 85. SOUTH AFRICA ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 86. REST OF LAMEA ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 87. REST OF LAMEA ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 88. REST OF LAMEA ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 89. LAMEA ALOPECIA TREATMENT MARKET, BY DRUG TYPE, 2018–2026
TABLE 90. LAMEA ALOPECIA TREATMENT MARKET, BY INDICATION, 2018–2026
TABLE 91. LAMEA ALOPECIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
LIST OF FIGURES
FIGURE 01. GLOBAL ALOPECIA TREATMENT MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS, 2018
FIGURE 03. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 04. MODERATE BARGAINING POWER OF BUYERS
FIGURE 05. MODERATE THREAT OF SUBSTITUTES
FIGURE 06. LOW THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE INTENSITY OF RIVALRY
FIGURE 08. IMPACT ANALYSIS
FIGURE 09. COMPARATIVE ANALYSIS OF MINOXIDIL ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 10. COMPARATIVE ANALYSIS OF FINASTERIDE ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 11. COMPARATIVE ANALYSIS OF OTHER DRUG TYPES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 12. COMPARATIVE ANALYSIS OF ANDROGENIC ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 13. COMPARATIVE ANALYSIS OF ALOPECIA AREATA ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS OF ALOPECIA TOTALIS ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF OTHERS ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF HOSPITALS PHARMACIES ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS DRUG STORES & RETAIL PHARMACIES ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF ONLINE PHARMACIES ALOPECIA TREATMENT MARKET, BY COUNTRY, 2018 & 2026 (%)
Alopecia is an autoimmune disorder, which cause hair fall from part of the head or body. It can be the result of medical conditions or medications, heredity, and hormonal changes. Treatment of alopecia condition consists of using drugs, scalp reduction treatment, and hair transplant & laser therapy.
Technological advancements in alopecia treatment products; increase in popularity of minoxidil drug; rise in number of pharmaceutical companies; increase in prevalence of chronic diseases such as cancer, hypertension, arthritis, and Polycystic Ovary Syndrome (PCOS); surge in consumption of alcohol & tobacco, and change in food habits significantly boost the growth of the alopecia treatment market. Moreover, increase in prevalence of alopecia conditions such as androgenic alopecia, alopecia areata, alopecia totalis, and others and surge in awareness programs for alopecia treatment & management fuel the growth of the global alopecia treatment market.
North America is expected to remain dominant during the forecast period due to higher adoption of alopecia treatment products with large presence of pharmaceutical and R&D laboratories. In addition, presence of advanced facilities and high availability of advanced systems supplement the growth of the market. Moreover, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period, due to developments in infrastructure of pharmaceutical industries along with rise in demand for alopecia treatment products.
Download Sample
Purchase Full Report of
Alopecia Treatment Market
- Online Only
- $3,456
- Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
- $3,840
- Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
- $5,370
- Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
- $6,450
- Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF - $8,995
- Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading instantly.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.